Blood advances
Treatment and Survival Outcomes in Follicular Lymphoma Patients with POD24: A Systematic Review and Meta-Analysis.
Jing Shen, Jingyi Zhang, Zhengyu Zhu, Haobo Ma, Junpeng Zhang, Fan Zhou, Hua Tian, JingHua Liu
Published: 202610.1182/bloodadvances.2025018474
Abstract
Follicular lymphoma (FL) with progression within 24 months (POD24) is associated with poor prognosis and represents clinical challenges. Therefore, we performed a systematic review and pooled analysis of patients with POD24. Twenty-one trials involvi…
Preview only. Read the full abstract at the source